Non-surgical Treatments for Urinary Incontinence in Adult Women: Diagnosis and Comparative Effectiveness
Comparative Effectiveness of Pharmacological Interventions (2 of 2)
Discontinuation rates due to adverse effects are higher with fesoterodine (18 events per 1,000 treated patients) and oxybutynin (55 events per 1,000 treated patients) than with tolterodine. The strength of evidence for the comparison of fesoterodine and tolterodine is moderate, and for the comparison with oxybutynin, the strength of evidence is high.
No statistically significant difference in discontinuation rate was found in comparisons of solifenacin and tolterodine. The strength of evidence for this finding is moderate.
For most head-to-head comparisons, only a single study was available for review, and the evidence is insufficient to permit conclusions about differences in the rates of benefits or adverse events.
- Shamliyan T, Wyman J, Sainfort F, et al. Nonsurgical Treatments for Urinary Incontinence in Adult Women: Diagnosis and Comparative Effectiveness. Comparative Effectiveness Review No. 36 (Prepared by the Minnesota Evidence-based Practice Center under Contract No. 290-2007-10064-I). Rockville, MD: Agency for Healthcare Research and Quality; April 2012. AHRQ Publication No. 11(12)-EHC074-EF. Available at www.effectivehealthcare.ahrq.gov/ui.cfm.
Your slide tray is being processed.